Legend Biotech
ISIN US52490G1022
|WKN A2P5AH
Market cap (in EUR)
2,930 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.
Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals United States
Financials
Key metrics
| Market capitalisation, EUR | 2,930 m |
| EPS, EUR | -1.43 |
| P/B ratio | 3.8 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2025)
| Revenue, EUR | 914 m |
| Net income, EUR | -264 m |
| Profit margin | -28.85% |
What ETF is Legend Biotech in?
There are 8 ETFs which contain Legend Biotech. All of these ETFs are listed in the table below. The ETF with the largest weighting of Legend Biotech is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| iShares MSCI AC Far East ex-Japan UCITS ETF | 0.01% | Equity Asia Pacific | 1,242 |
| iShares MSCI ACWI UCITS ETF USD (Acc) | 0.00% | Equity World | 24,501 |
| UBS Core MSCI EM UCITS ETF USD dis | 0.01% | Equity Emerging Markets | 2,248 |
| iShares MSCI EM UCITS ETF (Dist) | 0.01% | Equity Emerging Markets | 7,972 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.12% | Equity United States Health Care Biotech | 47 |
| Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist | 0.02% | Equity Emerging Markets | 975 |
| iShares MSCI EM IMI Screened UCITS ETF USD (Dist) | 0.01% | Equity Emerging Markets Social/Environmental | 1,169 |
| iShares MSCI EM ESG Enhanced CTB UCITS ETF USD (Dist) | 0.00% | Equity Emerging Markets Social/Environmental | 1,099 |
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.